| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 50242-094-47 | 50242-094 | HUMAN PRESCRIPTION DRUG | Rozlytrek | ENTRECTINIB | CAPSULE | ORAL | 20190815 | N/A | NDA | NDA212725 | Genentech, Inc. | ENTRECTINIB | 200 mg/1 | 1 BOTTLE in 1 CARTON (50242-094-47) / 90 CAPSULE in 1 BOTTLE |
| 50242-094-90 | 50242-094 | HUMAN PRESCRIPTION DRUG | Rozlytrek | ENTRECTINIB | CAPSULE | ORAL | 20190815 | N/A | NDA | NDA212725 | Genentech, Inc. | ENTRECTINIB | 200 mg/1 | 1 BOTTLE in 1 CARTON (50242-094-90) / 90 CAPSULE in 1 BOTTLE |
| 50242-091-86 | 50242-091 | HUMAN PRESCRIPTION DRUG | Rozlytrek | ENTRECTINIB | CAPSULE | ORAL | 20190815 | N/A | NDA | NDA212725 | Genentech, Inc. | ENTRECTINIB | 100 mg/1 | 1 BOTTLE in 1 CARTON (50242-091-86) / 30 CAPSULE in 1 BOTTLE |
| 50242-091-30 | 50242-091 | HUMAN PRESCRIPTION DRUG | Rozlytrek | ENTRECTINIB | CAPSULE | ORAL | 20190815 | N/A | NDA | NDA212725 | Genentech, Inc. | ENTRECTINIB | 100 mg/1 | 1 BOTTLE in 1 CARTON (50242-091-30) / 30 CAPSULE in 1 BOTTLE |